BioConsortia says its new biofungicide and bactericide, Amara, has received EPA registration. The product will protect fruit and vegetable crops from foliar diseases using a beneficial biological mode of action, according to a news release.
The company said the beneficial biological mode of action produces antimicrobial components that degrade fungal pathogens and promote systemic resistance in the plant, which controls and suppresses foliar diseases.
“The EPA approval of Amara biofungicide marks a major step for BioConsortia in the use of the company’s natural biologicals to help plants fight disease,” BioConsortia CEO Marcus Meadows-Smith said in the release. “The patented strain in Amara fungicide was discovered using our powerful biologicals discovery platform, AMS, that has been leveraged to develop a diverse pipeline of multiple leads to be commercialized through partners as products that combat disease, insects and nematodes, as well as for biostimulants and biofertilizers.”
Nichino America will market and sell Amara and plans to make the product available for use in the 2025 season, the release said.
“It is exciting to add a biological product to the Nichino portfolio and to bring this new technology to customers,” said Leigh Ann Harrison, product manager for Amara. “Amara will provide conventional and organic growers an effective solution for control of diseases on important crops, providing a quality yield while managing residues on the final commodity.”
